Vessi’s bladder-specific cryoablation technology may eliminate problems often reported with transurethral resection of bladder tumor (TURBT), today’s first line of treatment.

Leviticus Cardio and Jarvik Heart were awarded an R&D grant from the prestigious Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.

The procedures in Singapore with the ApiFix system “went exceptionally well and significant curve correction was achieved … .”

ZygoFix announced the successful start of a first in human clinical study for its zLOCK spinal facet joint fixation system.

Leviticus announced the successful completion of its groundbreaking 180-day preclinical study.

Here is our 10 Companies to Watch report for Q3 2018.

ApiFix announced its technology has now been used to treat more than 250 young patients diagnosed with progressive scoliosis.

Leviticus Cardio successfully completed a 90-day chronic animal study to evaluate its Coplanar Energy Transfer (CET) technology in combination with a commercial heart pump.

ApiFix was featured in the Canadian media.

Here is our 10 Companies To Watch report for Q2 2018.